Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan.
Ribera E, Martínez-Sesmero JM, Sánchez-Rubio J, Rubio R, Pasquau J, Poveda JL, Pérez-Mitru A, Roldán C, Hernández-Novoa B. Ribera E, et al. Among authors: hernandez novoa b. Enferm Infecc Microbiol Clin (Engl Ed). 2018 Mar;36(3):157-164. doi: 10.1016/j.eimc.2016.11.015. Epub 2017 Jan 20. Enferm Infecc Microbiol Clin (Engl Ed). 2018. PMID: 28109551 English, Spanish.
Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected.
Gutiérrez C, Díaz L, Vallejo A, Hernández-Novoa B, Abad M, Madrid N, Dahl V, Rubio R, Moreno AM, Dronda F, Casado JL, Navas E, Pérez-Elías MJ, Zamora J, Palmer S, Muñoz E, Muñoz-Fernández MÁ, Moreno S. Gutiérrez C, et al. Among authors: hernandez novoa b. PLoS One. 2011;6(12):e27864. doi: 10.1371/journal.pone.0027864. Epub 2011 Dec 8. PLoS One. 2011. PMID: 22174752 Free PMC article. Clinical Trial.
Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen.
Jarrin I, Hernández-Novoa B, Alejos B, Santos I, Lopez-Aldeguer J, Riera M, Gutiérrez F, Rubio R, Antela A, Blanco JR, Moreno S; Cohort of the Spanish HIV Research Network (CoRIS). Jarrin I, et al. Among authors: hernandez novoa b. HIV Med. 2014 Oct;15(9):547-56. doi: 10.1111/hiv.12144. Epub 2014 Mar 24. HIV Med. 2014. PMID: 24655804 Free article.
Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M, Vallejo A, Hernández-Novoa B, Díaz L, Gutiérrez C, Madrid N, Muñoz MA, Moreno S. Abad-Fernández M, et al. Among authors: hernandez novoa b. J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):149-53. doi: 10.1097/QAI.0b013e31829a2f12. J Acquir Immune Defic Syndr. 2013. PMID: 24047967 Clinical Trial.
Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients.
Hernández-Novoa B, Madrid-Elena N, Dronda F, Pérez-Elias MJ, Casado JL, Pérez-Molina JA, Moreno A, Estébanez M, González J, Zamora J, Moreno S. Hernández-Novoa B, et al. J Antimicrob Chemother. 2014 Jul;69(7):1916-9. doi: 10.1093/jac/dku059. Epub 2014 Mar 12. J Antimicrob Chemother. 2014. PMID: 24623833 Clinical Trial.
Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials.
Gutiérrez C, Hernández-Novoa B, Vallejo A, Serrano-Villar S, Abad-Fernández M, Madrid N, Díaz L, Moreno A, Dronda F, Zamora J, Muñoz-Fernández MA, Moreno S. Gutiérrez C, et al. Among authors: hernandez novoa b. AIDS. 2013 Aug 24;27(13):2081-8. doi: 10.1097/QAD.0b013e328361d0e1. AIDS. 2013. PMID: 24384589 Clinical Trial.
33 results